Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Anders

Showing results (451-460 of 701) with videos related to

Pageof 71
Sort By:
Vaccine|November 8, 2003
Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean childrenBlaise Genton, Fadwa Al-Yaman, Inoni Betuela, et al.
The Journal of Infectious Diseases|September 12, 2012
New insights into acquisition, boosting, and longevity of immunity to malaria in pregnant womenFreya J I Fowkes, Rose McGready, Nadia J Cross, et al.
Vaccine|April 7, 2005
A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvantAllan Saul, Greg Lawrence, Anthony Allworth, et al.
The Journal of Infectious Diseases|March 29, 2002
A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New GuineaBlaise Genton, Inoni Betuela, Ingrid Felger, et al.
Biochemistry|November 1, 2014
Structure and dynamics of apical membrane antigen 1 from Plasmodium falciparum FVOSan Sui Lim, Wei Yang, Bankala Krishnarjuna, et al.
Journal of Molecular Biology|February 13, 2017
Structure and Characterisation of a Key Epitope in the Conserved C-Terminal Domain of the Malaria Vaccine Candidate MSP2Jeffrey Seow, Rodrigo A V Morales, Christopher A MacRaild, et al.
Vaccine|November 4, 2008
Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in SudanNnaemeka C Iriemenam, Atif H Khirelsied, Amre Nasr, et al.
Journal of Molecular Biology|July 17, 2016
Structure-Activity Studies of β-Hairpin Peptide Inhibitors of the Plasmodium falciparum AMA1-RON2 InteractionGeqing Wang, Nyssa Drinkwater, Damien R Drew, et al.
Immunity|March 19, 2015
Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malariaMichelle J Boyle, Linda Reiling, Gaoqian Feng, et al.
Plos Pathogens|January 4, 2014
Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1Sheetij Dutta, Lisa S Dlugosz, Damien R Drew, et al.
Pageof 71

Showing results (451-460 of 701) with videos related to

Sort By:
Pageof 71
Vaccine|November 8, 2003
Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean childrenBlaise Genton, Fadwa Al-Yaman, Inoni Betuela, et al.
The Journal of Infectious Diseases|September 12, 2012
New insights into acquisition, boosting, and longevity of immunity to malaria in pregnant womenFreya J I Fowkes, Rose McGready, Nadia J Cross, et al.
Vaccine|April 7, 2005
A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvantAllan Saul, Greg Lawrence, Anthony Allworth, et al.
The Journal of Infectious Diseases|March 29, 2002
A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New GuineaBlaise Genton, Inoni Betuela, Ingrid Felger, et al.
Biochemistry|November 1, 2014
Structure and dynamics of apical membrane antigen 1 from Plasmodium falciparum FVOSan Sui Lim, Wei Yang, Bankala Krishnarjuna, et al.
Journal of Molecular Biology|February 13, 2017
Structure and Characterisation of a Key Epitope in the Conserved C-Terminal Domain of the Malaria Vaccine Candidate MSP2Jeffrey Seow, Rodrigo A V Morales, Christopher A MacRaild, et al.
Vaccine|November 4, 2008
Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in SudanNnaemeka C Iriemenam, Atif H Khirelsied, Amre Nasr, et al.
Journal of Molecular Biology|July 17, 2016
Structure-Activity Studies of β-Hairpin Peptide Inhibitors of the Plasmodium falciparum AMA1-RON2 InteractionGeqing Wang, Nyssa Drinkwater, Damien R Drew, et al.
Immunity|March 19, 2015
Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malariaMichelle J Boyle, Linda Reiling, Gaoqian Feng, et al.
Plos Pathogens|January 4, 2014
Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1Sheetij Dutta, Lisa S Dlugosz, Damien R Drew, et al.
Pageof 71